US · ALHC
Alignment Healthcare, Inc.
- Sector
- Healthcare · Medical - Healthcare Plans
- Headquarters
- Orange, CA 92868
- Website
- alignmenthealthcare.com
Price · as of 2025-12-31
$20.26
Market cap 3.85B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $35.08 | +73.15% |
| Intrinsic Value(DCF) | $2,338.74 | +11,443.63% |
| Graham-Dodd Method(GD) | $0.73 | -96.42% |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $0.00 | $0.00 | |||
| 2021 | $9.33 | $101.69 | $104.47 | $0.00 | $0.00 |
| 2022 | $6.08 | $28.54 | $160.75 | $0.00 | $0.00 |
| 2023 | $5.39 | $26.31 | $268.13 | $0.00 | $0.00 |
| 2024 | $14.89 | $36.94 | $1,695.86 | $0.00 | $0.00 |
| 2025 | $19.65 | $35.08 | $4,102.48 | $0.72 | $0.00 |
AI valuation
Our deep-learning model estimates Alignment Healthcare, Inc.'s (ALHC) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $35.08
- Current price
- $20.26
- AI upside
- +73.15%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$2,338.74
+11,443.63% upside
Graham-Dodd
$0.73
-96.42% upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| ALHC | Alignment Healthcare, Inc… | $20.26 | 3.85B | +73% | +11,444% | -96% | — | -5374.06 | 21.70 | 0.99 | 73.41 | — | 27.27 | 12.37% | 0.37% | -0.02% | -0.52% | -6.84% | -0.08% | 0.04 | 0.93 | 1.71 | 1.49 | -12.58 | -9945.00% | 4606.00% | -220480.00% | 3.60% | 0.25 | -64.84% | 0.00% | 0.00% | 11.97% | 225.15 | 23.74 | 0.84 | 5.50 |
| APGE | Apogee Therapeutics, Inc. | $70.00 | 3.84B | — | — | — | — | -10.95 | 2.78 | — | -6.86 | -11.08 | 2.78 | 0.00% | — | — | -33.22% | -223.05% | -31.53% | 0.02 | — | 18.55 | 18.39 | 0.60 | 9880.00% | — | 12999.00% | -8.64% | -5.99 | -177.24% | 0.00% | 0.00% | 0.69% | -6.85 | -8.62 | — | 31.49 |
| DYN | Dyne Therapeutics, Inc. | $15.62 | 2.57B | — | — | — | — | -3.68 | 1.85 | — | -1.74 | — | 1.85 | 0.00% | — | — | -88.03% | -9599.05% | -74.14% | 0.04 | — | 15.60 | 15.20 | 1.31 | -1468.00% | — | 5604.00% | -25.25% | -6.92 | -8227.36% | 0.00% | 0.00% | 27.18% | -1.60 | -1.86 | — | 8.91 |
| GRAL | GRAIL, Inc. | $53.23 | 2.08B | -54% | -60% | -73% | — | — | 0.75 | 13.14 | -2.99 | — | 2.66 | -42.52% | -362.95% | -277.47% | 0.00% | -22.80% | 0.00% | 0.04 | — | 11.97 | 11.58 | 0.40 | -8251.00% | 1718.00% | -4866.00% | -15.46% | -3.75 | -16.71% | 0.00% | — | 0.29% | -2.11 | -3.77 | 7.66 | -1.71 |
| ICUI | ICU Medical, Inc. | $150.58 | 3.72B | -14% | -61% | -83% | -100% | 4947.86 | 1.71 | 1.62 | 14.41 | — | -381.73 | 36.76% | 4.80% | 0.03% | 0.04% | 1.32% | 0.02% | 0.66 | 1.01 | 2.36 | 0.98 | 3.32 | -10061.00% | -638.00% | -2636.00% | 2.53% | 0.36 | 2.82% | 0.00% | 0.00% | 7.11% | 44.00 | 51.26 | 2.11 | 2.21 |
| MIRM | Mirum Pharmaceuticals, In… | $92.29 | 4.77B | -16% | +4,973% | -96% | — | -193.57 | 14.37 | 8.67 | 259.00 | — | 84.11 | 80.71% | -4.25% | -4.48% | -8.65% | -8.65% | -3.09% | 1.01 | -1.54 | 2.67 | 2.46 | 1.20 | -7459.00% | 5474.00% | 48801.00% | 1.21% | 0.27 | 21.44% | 0.00% | 0.00% | 1.65% | -201.32 | 81.21 | 8.55 | 5.05 |
| NVST | Envista Holdings Corp | $29.21 | 4.8B | +59% | -47% | -80% | -85% | 105.23 | 1.59 | 1.82 | 15.93 | — | 40.91 | 55.02% | 8.30% | 1.73% | 1.56% | 2.57% | 0.85% | 0.55 | 6.17 | 2.38 | 1.93 | 1.45 | -10431.00% | 832.00% | -2389.00% | 4.66% | 0.32 | 6.57% | 0.00% | 0.00% | 3.37% | 24.11 | 23.62 | 2.00 | 1.90 |
| OSCR | Oscar Health, Inc. | $13.64 | 3.54B | +238% | +3,520% | — | — | -8.28 | 3.75 | 0.31 | -0.28 | — | 3.75 | 14.38% | -3.39% | -3.79% | -44.49% | 23.17% | -7.93% | 0.44 | -22.52 | 0.95 | 0.91 | 5.99 | -186594.00% | 2750.00% | 1138.00% | 28.86% | 0.23 | -61.87% | 0.00% | 0.00% | 30.44% | -0.27 | 0.10 | 0.01 | 1.28 |
| PRVA | Privia Health Group, Inc. | $23.75 | 2.92B | +1,602% | +12,603% | +22,024% | +23,094% | 0.10 | 0.00 | 1.38 | -8677.07 | 0.16 | 0.01 | 9.40% | 1.61% | 1079.64% | 8.06% | 0.02% | 4.34% | 0.01 | — | 1.60 | 1.55 | -8731.62 | 6364.00% | 2226.00% | 15646682.00% | 5557.73% | 0.29 | 122.18% | 0.00% | 0.00% | 15990.70% | -13647.35 | -2.86 | -220.09 | 0.14 |
| RARE | Ultragenyx Pharmaceutical… | $23.39 | 2.26B | -15% | -61% | — | — | -3.95 | -28.37 | 3.37 | -5.71 | — | -7.57 | 83.80% | -79.49% | -85.44% | -656.03% | -567.31% | -37.89% | -15.95 | -8.63 | 2.48 | 2.22 | -1.68 | -731.00% | 2013.00% | 1193.00% | -20.80% | -1.21 | -500.50% | 0.00% | 0.00% | 0.00% | -5.33 | -6.04 | 4.24 | -3.56 |
| SLNO | Soleno Therapeutics, Inc. | $39.07 | 2.1B | — | -51% | -73% | — | 99.43 | 4.61 | 10.91 | 62.51 | — | 4.66 | 98.58% | 7.85% | 10.97% | 6.01% | 19.44% | 4.67% | 0.01 | 2.73 | 5.80 | 5.44 | -2.38 | -10890.00% | — | -16741.00% | 2.25% | 0.76 | 60.75% | 0.00% | 0.00% | 6.38% | 118.68 | 37.97 | 9.32 | 10.94 |
About Alignment Healthcare, Inc.
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.
- CEO
- John E. Kao
- Employees
- 1.68K
- Beta
- 1.17
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($2,338.74 ÷ $20.26) − 1 = +11,443.63% (DCF, example).